Delivery Order SPE2DB24D2010-SPE2DB25FZVG8

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 50 MG CAPSULE 100S. The contract has a firm fixed price of $1,724.00 and an ultimate completion date of July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.10 firm fixed-price contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has a completion date of January 23, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $2,427.18 firm fixed price contract is for the provision of VYVANSE 50 MG CAPSULE 100S, a prescription medication. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $3,643.90, is for the supply of 4,564,878,409 units of the prescription medication VYVANSE 50 MG CAPSULE 100S. The contract has a firm fixed price with a completion date of June 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a $5,007.92 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 10 MG CAPSULE 100S, a medication used for treating conditions such as ADHD. The delivery order has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,444.89 firm fixed price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of November 16, 2023 and was awarded on November 15, 2023. This contract is not designated as a set-aside and appears to be...
The U.S. Defense Logistics Agency (DLA) awarded a $1,293.00 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the provision of 4565519574 - VYVANSE 50 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $17,884.74 and has an ultimate completion date of December 19, 2023. The contract is for the delivery of 4563162332 units of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,948.02, is for the delivery of VYVANSE 10 MG CAPSULE 100S, a prescription medication used for the treatment of attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,927.20 firm-fixed-price contract is for the delivery of 4,565,638,359 units of the prescription drug VYVANSE 30 MG CAPSULE 100S. The order has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZVG8
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,833.11 contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of February 12, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/13/25, 10:19 AM